SCHEMBL70765

SCHEMBL70765

O=C(O)c1cccc(-c2cccc(C(=O)O)n2)n1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.76
ALOX15 P16050 1/20 0.76
TSHR P16473 1/20 0.76
ACMSD Q8TDX5 1/20 0.76
TDP1 Q9NUW8 1/20 0.76
ECE1 P42892 1/20 0.65
PDE4A P27815 2/20 0.53
PDE4B Q07343 2/20 0.53
PDE4C Q08493 2/20 0.53
PDE4D Q08499 2/20 0.53
PADI1 Q9ULC6 1/20 0.53
PADI3 Q9ULW8 1/20 0.53
PADI4 Q9UM07 1/20 0.53
PADI2 Q9Y2J8 1/20 0.53
LMNA P02545 3/20 0.52
GNE Q9Y223 1/20 0.50
KMT2A Q03164 2/20 0.48
MGAM O43451 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
P4HTM Q9NXG6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357675 1.00 KDM4E (0.76) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL143651 0.98 KDM4E (0.73) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL29355234 0.98 KDM4E (0.73) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL23069157 0.95 KDM4E (0.70) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL29446940 0.95 KDM4E (0.70) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL1456359 0.91 KDM4E (0.64) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL3753307 0.89 KDM4E (0.61) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL17258354 0.88 KDM4E (0.59) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL15452283 0.88 KDM4E (0.59) KDM4EALOX15TSHRACMSDTDP1
SCHEMBL2841904 0.88 ECE1 (0.63) KDM4EALOX15TSHRACMSDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250362307-A1 PHOTOACTIVE ANTIBODY CONJUGATE LIAO JUNG CHI (TW) 2025-11-27 US claimed
EP-4473309-A1 PHOTOACTIVE ANTIBODY CONJUGATE Syncell (Taiwan) Inc. (TW) 2024-12-11 EP claimed
WO-2023196986-A1 PHOTOACTIVE ANTIBODY CONJUGATE Syncell (Taiwan) Inc. (TW) 2023-10-12 WO claimed
US-11658309-B2 Ammonia fuel cell THE UNIVERSITY OF TOKYO (JP) 2023-05-23 US claimed
US-20220158202-A1 AMMONIA FUEL CELL THE UNIVERSITY OF TOKYO (JP) 2022-05-19 US claimed
CN-112210082-A Europium/copper bimetallic modified zinc coordination polymer material and preparation method and application thereof 浙江师范大学 2021-01-12 CN claimed
CN-102380424-A Heteropoly acid zeolite coated rare earth-organic framework material and its preparation method UNIV NANKAI 2012-03-21 CN claimed
US-20250362307-A1 PHOTOACTIVE ANTIBODY CONJUGATE LIAO JUNG CHI (TW) 2025-11-27 US disclosed
US-20250002818-A1 CLEANING SOLUTION, METHOD FOR CLEANING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR TOKYO OHKA KOGYO CO., LTD. (JP) 2025-01-02 US disclosed
EP-4473309-A1 PHOTOACTIVE ANTIBODY CONJUGATE Syncell (Taiwan) Inc. (TW) 2024-12-11 EP disclosed
US-11935803-B2 Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-03-19 US disclosed
WO-2023196986-A1 PHOTOACTIVE ANTIBODY CONJUGATE Syncell (Taiwan) Inc. (TW) 2023-10-12 WO disclosed
US-11658309-B2 Ammonia fuel cell THE UNIVERSITY OF TOKYO (JP) 2023-05-23 US disclosed
US-20090143419-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES HATCHTECH PTY LTD (AU) 2009-06-04 US disclosed
WO-2009047584-A1 COMBINATION COMPOSITIONS AND METHODS OF USE OF THE SAME FOR CONTROLLING INFESTATION HATCHTECH PTY. LTD. (AU) 2009-04-16 WO disclosed
US-20070254907-A1 COMPOSITIONS AND METHODS FOR CONTROLLING INFESTATION HATCHTECH PTY LTD (AU) 2007-11-01 US disclosed
EP-1845782-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES Hatchtech Pty Ltd (AU) 2007-10-24 EP disclosed
WO-2006076761-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES HATCHTECH PTY LTD (AU) 2006-07-27 WO disclosed
EP-1653997-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES Hatchtech Pty Ltd (AU) 2006-05-10 EP disclosed
WO-2005007188-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES HATCHTECH PTY LTD (AU) 2005-01-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254907-A1 COMPOSITIONS AND METHODS FOR CONTROLLING INFESTATION ME3, ACHE, SGMS2 KDM4E 587/4885ALOX15 1545/4885TSHR 4273/4885
US-20090143419-A1 METHODS AND COMPOSITIONS FOR CONTROLLING ECTOPARASITES CAT, CTRL, SOD3 KDM4E 2314/4885ALOX15 1326/4885TSHR 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.